Logo for Theratechnologies Inc

Theratechnologies Investor Relations Material

Latest events

Logo for Theratechnologies Inc

Q1 2025

Theratechnologies
Logo for Theratechnologies

Q1 2025

9 Apr, 2025
Logo for Theratechnologies

Q4 2024

26 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Theratechnologies Inc

Access all reports
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in cardiology, oncology, and women's health. The company primarily develops peptide-based therapeutics. Its product candidates include Onbrez Breezhaler, which is in Phase III clinical trial for the symptomatic relief of chronic obstructive pulmonary disease; and Theratears for Atopic Keratoconjunctivitis (MK), which is under Phase III clinical trial for the treatment of atopic keratoconjunctivitis. Theratechnologies Inc is headquartered in Montreal, Canada.